Clinical Trial Update: Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ginkgo biloba extract for cognitive problems in multiple sclerosis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Multiple Sclerosis, Cognitive Ability, General | Phase 2 | Status: COMPLETED | Results posted: 2014-05-05